PBM contracts shape critical decisions that impact healthcare costs, compliance, and patient outcomes. Securing the right terms can dramatically improve pharmacy plan performance and member care. Here’s what you need to know about PBM contract requirements, how to negotiate better terms, and how to avoid common pitfalls.. Additionally, we explore future trends in PBM contracting, framing the importance of using a centralized platform to perfect negotiations using outcome-based solutions.
Understanding PBM Contracts
PBM contracts act like a series of hidden levers, determining the expectations between healthcare organizations and the financial and clinical outcomes that ultimately impact member health.
Mastering the structure and strategic purpose of PBM contracts is essential for healthcare stakeholders seeking to optimize their pharmacy benefit arrangements.
How Do PBM Contracts Work?
PBM contracts establish the terms and conditions determining the services PBMs provide, such as:
- Claims processing
- Formulary management
- Pharmacy network administration
- Rebate negotiation
These contracts outline important financial arrangements, drug pricing methodologies, fee structures, and other vital details, including performance expectations, reporting, and audit provisions.
Types of PBM Contracts
PBM contracts include the following forms:
Traditional (Fee-for-Service) Contracts: Health plans pay PBMs a fee for specific services, passing drug costs through to the health plan and providing a manufacturer’s rebate to the PBM.
Shared Savings Contracts: PBMs generate shared cost savings by promoting generic drugs, improved utilization, and other methods.
Risk-Based Contracts: PBMs bear financial risk for drug spending by placing caps on drug costs to improve predictability for health plans and similar scenarios. This requires well-researched performance reporting and careful negotiations.
Who Do PBMs Contract With?
PBMs primarily contract with health plans, insurers, employers, and government agencies like Medicare and Medicaid.
Key PBM Contract Requirements
Clear terms and expectations, defining each party’s obligations, ensure the most equitable outcome for contracts between PBMs, health plans, and other primary healthcare organizations.
Pricing Transparency: Ensuring Clarity on Drug Costs, Rebates, and Reimbursement Structures
Pricing transparency is foundational for managing drug spend, budgeting, and performance evaluations.
Contracts should leave no room for ambiguity with details like:
Average Wholesale Price (AWP): The contract should specify the AWP, discount applied, and any potential adjustments for drug type or volume.
Maximum Allowable Cost (MAC) Pricing: There should be details regarding how the MAC list is developed, updated, and maintained.
Dispensing Fees: All fees for pharmacy types or drug volume should be defined.
Ingredient Cost: They should specify how ingredient costs are determined.
Rebate Details: Contracts should clearly explain calculations and factors impacting rebate values, percentages for included drugs, and payment schedules from manufacturers to PBMs and from PBMs to health plans.
Reimbursement Structure Transparency: Contracts must clearly itemize administrative fees, claims processing fees, and other charges.
Rebate & Discount Agreements
Rebates significantly reduce prescription drug costs when properly negotiated. Three key types impact your bottom line:
- Market Share Rebates: Based on market share of specific drugs
- Formulary Rebates: Tied to formulary placement
- Performance-Based Rebates: Linked to measurable outcomes
These rebates may differ based on classification, competition, utilization, and other factors. Negotiating rebates involves contractual clarity, and data analytics help identify opportunities for implementing clinically beneficial high-rebate drugs in plans.
Performance Guarantees: Setting Clear KPIs for PBM Performance and Accountability
Performance guarantees establish measurable expectations and create accountability for effective pharmacy benefit management.
Contracts should outline specific KPIs aligned with health plan objectives, following SMART principles (Specific, Measurable, Achievable, Relevant, Time-Bound).
KPIs should include:
- Authorization approval rates
- Step therapy success
- Call center response times
- Per-member-per-month (PMPM) cost savings
- Generic dispensing rates
- Reporting data, including raw data for audits
Contracts must also clearly outline accountability, which includes financial penalties for underperformance, service level agreements (SLAs), and termination terms.
Audit & Data Access Rights
Robust audit and data access rights are essential for health plans to monitor PBM performance, ensure compliance, and identify cost-saving opportunities. Audits should explicitly grant transparency to the right partners, including terms for the frequency of audits, specific security access, and details regarding real-time data.
This ensures the health plan’s ability to proactively intervene by identifying drug utilization trends and preventing potential fraud or abuse.
Formulary & Utilization Management: Negotiating Terms That Align With Health Plan Goals
Formulary and utilization management provisions are critical for controlling drug costs while ensuring medication access and optimizing clinical outcomes.
Drug formularies are lists of covered prescriptions from which health plans can select:
- Open formularies that cover the majority of medications with few restrictions
- Closed formularies limiting coverage to cost-effective solutions
- Preferred drug lists with tiered cost-sharing options
Negotiations consider clinical guidelines, strategies for promoting cost-effective solutions that increase access to medication and strategies for establishing the process for changes to formularies.
Effective utilization management strategies are critical for ensuring appropriate medication use. Examples include:
- Prior authorization for high-cost medications
- Step therapy
- Quantity limits
- Drug utilization reviews
Common Pitfalls and Best Practices in PBM Contracts
The following are contractual pitfalls and how to avoid them:
Hidden Fees and Clawbacks
Hidden fees and clawbacks can be a source of additional charges for processing, management services, and other fees that should all be clearly and specifically anticipated in contractual terms.
Avoiding these pitfalls requires clear fee schedules for all services, defining all pricing terms, establishing reimbursement rates, and outlining all auditing provisions clearly. If fees are tied to penalties for underperformance, all terms must be clearly defined, and there must be straightforward mechanisms for protecting stakeholders through data visibility, auditing, and reporting requirements.
Non-Transparent Rebate Structures
Rebates can impact medication net costs, making transparency in this area critical for health plans to maximize value. When PBMs negotiate manufacturer rebates, they must disclose all details to health plans. Confusion can stem from unclear rebate amounts, complex calculation formulas, confidentiality, and delays.
To mitigate these risks, ensure contracts have clear language regarding rebate schedules, formulas, auditing, reporting, and pass-through arrangements that establish a clear maximum value.
Restrictive Audit Clauses
Audit rights and data access are crucial for effectively overseeing PBM performance and verifying contract compliance.
Contracts may limit auditing or data access by narrowing the scope of audits or requiring excessive notification terms. This can prevent accurate billing information, claims processing, and rebate data.
Negotiating for fewer audit restrictions and reasonable notice helps ensure fair practices. This includes transparency for claims data, ongoing performance reporting, and unambiguous contract language.
Misaligned Performance Metrics
Contracts can include metrics that don’t support cost control or improved patient outcomes if they focus solely on discounts without accounting for clinical appropriateness, utilization, and outcomes.
Aligned metrics should balance cost and quality, ensuring treatment is tied to clinical appropriateness, medical adherence, and reducing hospitalization, to name a few factors. This can be enforced through regular metric reviews, adjusting KPIs for alignment.
Lack of Flexibility in Formulary Management
Formulary management requires adapting to new drugs, clinical evidence, and market changes. Inflexible contracts hinder the optimization of drug therapy and cost control.
Rigid formulary structures may be overly restrictive regarding rules such as:
- Term reviews
- Process changes
- Drug exclusions
This can lead to missed cost-saving opportunities, delayed access to therapies, and poor patient outcomes.
Negotiating for frequent reviews, efficient modification processes, and clear pathways for drug exclusions helps prevent negative patient results.
The Future of PBM Contract Negotiations
Contract negotiations are evolving as healthcare embraces AI and automation to secure better PBM terms — shifting away from traditional spreadsheets toward outcomes-based agreements. How AI and Automation Will Shape PBM Contracts
AI and automation are transforming contract design- through enhanced efficiency, accuracy, and strategic insights.
Data Analysis and Insights
AI analyzes claims, pricing, and clinical information, identifying trends, patterns, and anomalies. It provides comprehensive insights into utilization patterns, cost drivers, and savings opportunities.
Automation streamlines this data to determine terms regarding reporting and auditing and for key decision-making.
Contract Modeling and Simulation
AI enables the modeling of different contract scenarios and the simulation of their potential impact on costs and outcomes. Automation facilitates the development of models based on huge datasets that are accurate and based on real information.
Negotiation Support
AI provides real-time negotiation support by analyzing counterproposals, identifying potential concessions, and suggesting optimal strategies. Automation facilitates creating and managing complex contract models.
Contract Monitoring and Compliance
AI continuously monitors contract performance to identify any deviations from terms and pairs with automation to provide users with notifications and alerts.
The Growing Emphasis on Outcomes-Based Contracts and Value-Based Pricing
The industry is shifting toward contracts structured around patient outcomes and value rather than traditional volume-based models.
Outcomes-based contracts allow for contractual terms based around health metrics so that PBMs can align cost savings and compensation to patient well-being. When stakeholder incentives are tied to better patient health, everybody wins.
With value-based pricing, medication prices connect directly to better patient health. In old models, cost was always a prohibitive factor, but data shows early expenses only tell the beginning of the story. As patient health improves with proper medication, healthcare costs are reduced, leading to long-term plan savings. This formula allows for specialty and high-cost therapies where they can balance savings in the long run.
Securing better results, savings, and compensation models requires advanced methods for collecting and analyzing data, which means PBMs need the most advanced platform features for pricing models, tracking tools, recognizing trends, and analyzing results.
Negotiate the Best Terms with Insights from Xevant
Securing optimal contract terms demands a strategic, data-driven approach grounded in transparency, alignment, and flexibility to yield the best outcomes.
Ready to transform your approach to PBM contract negotiations? Discover how Xevant’s real-time analytics platform can empower your team with the data insights that shape better contract terms and optimize pharmacy benefits programs.
Book a demo today to see Xevant in action.
